Dr. Reddys Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Quarterly Results    (REDY)

Here are the latest quarterly results of Dr. Reddys. For more details, see the Dr. Reddys financial fact sheet and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Dr. Reddys Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m40,29638,58248,12843,97144,48944,26549,10949,419 
Other income Rs m8334,301540673736871512705 
Turnover Rs m41,12942,88348,66844,64445,22545,13649,62150,124 
Expenses Rs m32,10731,16537,49046,85834,99733,05237,54844,026 
Gross profit Rs m8,1897,41710,638-2,8879,49211,21311,5615,393 
Depreciation Rs m2,8722,8903,1312,8692,7412,9233,1653,112 
Interest Rs m245298303152230233252188 
Profit before tax Rs m5,9058,5307,744-5,2357,2578,9288,6562,798 
Tax Rs m1,5081,928-3,207325-4493,0591,0112,670 
Profit after tax Rs m4,3976,60210,951-5,5607,7065,8697,645128 
Gross profit margin %20.319.222.1-6.621.325.323.510.9 
Effective tax rate %25.522.6-41.4-6.2-6.234.311.795.4 
Net profit margin %10.917.122.8-12.617.313.315.60.3 
Diluted EPS Rs 26.5 39.8 66.1 -33.6 46.5 35.4 46.1 0.8  
Diluted EPS (TTM) Rs 115.5 126.6 162.1 98.9 118.9 114.5 94.5 128.8  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Dr. Reddys 3QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   DISHMAN PHARMA  AUROBINDO PHARMA  VENUS REMEDIES  FULFORD INDIA  ASTRAZENECA PHARMA  

Compare DR. REDDYS LAB With:   DISHMAN PHARMA  AUROBINDO PHARMA  VENUS REMEDIES  FULFORD INDIA  ASTRAZENECA PHARMA  

Compare DR. REDDYS LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Views on news

Most Popular

A Critical Update on the Market (Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy (Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers (Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Apr 9, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - ACTAVIS COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS